Market Cap 65.53M
Revenue (ttm) 0.00
Net Income (ttm) -15.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,184,000
Avg Vol 498,488
Day's Range N/A - N/A
Shares Out 8.15M
Stochastic %K 15%
Beta -0.77
Analysts Strong Sell
Price Target $27.40

Company Profile

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1...

Industry: Biotechnology
Sector: Healthcare
Phone: 913 942 2300
Address:
1901 West 47th Place, Kansas City, United States
stagefiveCINGer
stagefiveCINGer Mar. 21 at 9:04 PM
$CING So as far as I know, John Vandermosten knows what’s up with this company. Why would he write that they’re targeting launch for 2027. Feel like this surprise new would tank tank stock if true
0 · Reply
DonkeyClanbrands
DonkeyClanbrands Mar. 21 at 4:57 PM
$CING does anyone know if we will get updates on the CMC elements pre may31? Would love for shane and co to get out in front of it if possible
1 · Reply
biospeculator
biospeculator Mar. 21 at 12:18 PM
$CING Using Elliot wave on a single stock vs. an ETF or Index is somewhat like herding cats (cat owner), lol. But we had a clear 5 wave, WAVE I from $3-$12. Now we are in Wave II which is typically an ABC correction. Without a delay $7 would hold and with a delay the target is $5. Then Wave III the most powerful wave of the move would be 2x wave I ($9) or $18 for a target of $25-$30. Of course, a buyout or denial (highly unlikely) would change things. So, simple question is do you try and buy $2 lower and miss $20 upside? I am long and will simply buy more if a delay occurs because a few extra months vs. 400%- 1000% upside is worth the wait imo. GLTA
4 · Reply
alfi79
alfi79 Mar. 21 at 10:37 AM
0 · Reply
History101
History101 Mar. 21 at 2:34 AM
$CING loaded up in the $6.80 range early this morning on the deep dip, CING was one of my best performers today on a deep red market day. GLTALs!!
1 · Reply
fullobullz
fullobullz Mar. 21 at 2:17 AM
$CING Prasad is out from fda, bullish AF !!
1 · Reply
biotechs2021
biotechs2021 Mar. 20 at 9:46 PM
$CING can someone just ELI5 what happened? Did the FDA not approve? Why the huge change in momentum? SMH
2 · Reply
alfi79
alfi79 Mar. 20 at 9:12 PM
0 · Reply
Laacy
Laacy Mar. 20 at 9:09 PM
0 · Reply
basssque
basssque Mar. 20 at 8:29 PM
$CING Anybody able to trade options here with their brokerage?
2 · Reply
Latest News on CING
Why did Cingulate stock skyrocket today?

Mar 16, 2026, 1:26 PM EDT - 5 days ago

Why did Cingulate stock skyrocket today?


Cingulate Provides Management Team Update

Aug 15, 2025, 9:00 AM EDT - 7 months ago

Cingulate Provides Management Team Update


Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

Sep 12, 2024, 8:30 AM EDT - 1 year ago

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301


Cingulate to Participate in Benzinga All Live Access Event

Aug 27, 2024, 4:30 PM EDT - 1 year ago

Cingulate to Participate in Benzinga All Live Access Event


Cingulate Announces Adjournment of Special Meeting

Aug 23, 2024, 4:45 PM EDT - 1 year ago

Cingulate Announces Adjournment of Special Meeting


Cingulate to Attend DCAT Week 2024 in New York City

Mar 6, 2024, 6:45 AM EST - 2 years ago

Cingulate to Attend DCAT Week 2024 in New York City


Cingulate Announces Closing of $7.5 Million Public Offering

Feb 6, 2024, 4:15 PM EST - 2 years ago

Cingulate Announces Closing of $7.5 Million Public Offering


Cingulate Announces Pricing of $7.5 Million Public Offering

Feb 2, 2024, 9:15 AM EST - 2 years ago

Cingulate Announces Pricing of $7.5 Million Public Offering


Longtime Cingulate Controller Jennifer Callahan Promoted to CFO

Jan 29, 2024, 8:00 AM EST - 2 years ago

Longtime Cingulate Controller Jennifer Callahan Promoted to CFO


Cingulate to Host CNS Key Opinion Leader Panel in New York City

Oct 17, 2023, 2:22 PM EDT - 2 years ago

Cingulate to Host CNS Key Opinion Leader Panel in New York City


Cingulate Inc. to Present at the LD Micro Main Event XVI

Sep 21, 2023, 1:30 PM EDT - 2 years ago

Cingulate Inc. to Present at the LD Micro Main Event XVI


Cingulate Inc. To Present at the LD Micro Main Event XVI

Sep 21, 2023, 11:23 AM EDT - 2 years ago

Cingulate Inc. To Present at the LD Micro Main Event XVI


Cingulate Announces Closing of $4.0 Million Public Offering

Sep 13, 2023, 4:15 PM EDT - 2 years ago

Cingulate Announces Closing of $4.0 Million Public Offering


Cingulate Announces Pricing of $4.0 Million Public Offering

Sep 11, 2023, 9:22 AM EDT - 2 years ago

Cingulate Announces Pricing of $4.0 Million Public Offering


stagefiveCINGer
stagefiveCINGer Mar. 21 at 9:04 PM
$CING So as far as I know, John Vandermosten knows what’s up with this company. Why would he write that they’re targeting launch for 2027. Feel like this surprise new would tank tank stock if true
0 · Reply
DonkeyClanbrands
DonkeyClanbrands Mar. 21 at 4:57 PM
$CING does anyone know if we will get updates on the CMC elements pre may31? Would love for shane and co to get out in front of it if possible
1 · Reply
biospeculator
biospeculator Mar. 21 at 12:18 PM
$CING Using Elliot wave on a single stock vs. an ETF or Index is somewhat like herding cats (cat owner), lol. But we had a clear 5 wave, WAVE I from $3-$12. Now we are in Wave II which is typically an ABC correction. Without a delay $7 would hold and with a delay the target is $5. Then Wave III the most powerful wave of the move would be 2x wave I ($9) or $18 for a target of $25-$30. Of course, a buyout or denial (highly unlikely) would change things. So, simple question is do you try and buy $2 lower and miss $20 upside? I am long and will simply buy more if a delay occurs because a few extra months vs. 400%- 1000% upside is worth the wait imo. GLTA
4 · Reply
alfi79
alfi79 Mar. 21 at 10:37 AM
0 · Reply
History101
History101 Mar. 21 at 2:34 AM
$CING loaded up in the $6.80 range early this morning on the deep dip, CING was one of my best performers today on a deep red market day. GLTALs!!
1 · Reply
fullobullz
fullobullz Mar. 21 at 2:17 AM
$CING Prasad is out from fda, bullish AF !!
1 · Reply
biotechs2021
biotechs2021 Mar. 20 at 9:46 PM
$CING can someone just ELI5 what happened? Did the FDA not approve? Why the huge change in momentum? SMH
2 · Reply
alfi79
alfi79 Mar. 20 at 9:12 PM
0 · Reply
Laacy
Laacy Mar. 20 at 9:09 PM
0 · Reply
basssque
basssque Mar. 20 at 8:29 PM
$CING Anybody able to trade options here with their brokerage?
2 · Reply
fullobullz
fullobullz Mar. 20 at 7:47 PM
$CING My guess is that $5's next week is unlikely to happen and alot of nonsense unless something new and negative happens. Without negative news we go sideways or start to move up again. If something negative happens and $6.60 doesn't hold again then we see $5's. Just imo tho
1 · Reply
fullobullz
fullobullz Mar. 20 at 7:34 PM
$CING Based on fda historical data, here's my guess at the probability table timeframe for WL Risk: Feb–early March High (25–35%) Mid-March–April Moderate (15–20%) April–early May Low (5–10%) May → PDUFA Very Low (2–5%)
0 · Reply
geegor
geegor Mar. 20 at 7:30 PM
"Welcome to $CING - A - POOR 🇸🇬 Due to minor unexpected turbulence on our approach today, please remain seated with your seatbelts fastened until we have come to a complete stop. For those passengers who are transiting to the moon, your onward flight may have been delayed. Please await reboarding confirmation and further instructions from ground staff inside the terminal. Thank you for flying FDA."
0 · Reply
EFhutton420
EFhutton420 Mar. 20 at 6:15 PM
$CING should see a $5 handle next week. We'll see under $5 after the CRL. The CRL will not come before May 31 but they may get a warning letter late next month. With the low float and panic selling, could see $3.60
2 · Reply
BigD12plus
BigD12plus Mar. 20 at 6:04 PM
$CING Missed the boat this morning but this is shaping up to be a nice entry point as well 😎
0 · Reply
History101
History101 Mar. 20 at 6:02 PM
$CING hit $6.80 again today and i buy another block just like i did this morning...GLTALs!!
0 · Reply
BigD12plus
BigD12plus Mar. 20 at 5:52 PM
$CING Not bad! Not bad at all.
1 · Reply
I_Buy_Stock
I_Buy_Stock Mar. 20 at 5:15 PM
$CING Nowhere in their press release or 10k is it mentioned that: "Management now targets 1H:27 for a full commercial launch" Why did you put that in the article? Did management tell John Vandermosten this directly? Where did he get the information that their target date has changed?
2 · Reply
Juhanialainen
Juhanialainen Mar. 20 at 4:56 PM
$CING Looks like a triangle trading to me. Should be fine and could see $8 today.
1 · Reply
ZacksResearch
ZacksResearch Mar. 20 at 4:53 PM
$CING burning more cash—but the real story is the FDA clock ⏳ Net loss widened to $22.4M (vs $16.6M YoY) as G&A jumped on pre-commercialization, while cash sits at ~$11M with runway into late 2026. Meanwhile, the NDA for CTx-1301 is under FDA review with a PDUFA date of May 31, 2026—a major catalyst. See what Wall Street expects next 👉 https://www.zacks.com/stock/research/CING/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-37442&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_37442
1 · Reply
Juhanialainen
Juhanialainen Mar. 20 at 4:41 PM
$CING I bought some back. Should reverse at least a bit in the short term from that drastic fall. Long term seeing tremendous upside. A bumpy ride here, whereas Sellas keeps on a steady climb along Elliot Waves like a true champ!
0 · Reply
LimeLicker_1
LimeLicker_1 Mar. 20 at 4:24 PM
$CING Lunch break and then a second bump up for the day? Setup looks nice.
0 · Reply